2018
DOI: 10.1016/j.ajo.2018.03.031
|View full text |Cite
|
Sign up to set email alerts
|

Pars Plana Vitrectomy for the Treatment of Uveitis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
19
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
5
2

Relationship

1
6

Authors

Journals

citations
Cited by 31 publications
(20 citation statements)
references
References 41 publications
1
19
0
Order By: Relevance
“…5 These results were similar to our findings of cases with a combined PCIOL/PPV (62% vs 62.4% at 9 months and final follow-up, respectively) and those with vitrectomy only. 5,12 Overall, nearly 85% of the patients in our study had an improvement in BCVA at their last follow-up compared with preoperative BCVA despite ocular comorbidities. Thus, a combined approach resulted in favorable outcomes despite the longer, more complicated surgery while also increasing the chance of disease remission.…”
Section: Discussionmentioning
confidence: 72%
See 1 more Smart Citation
“…5 These results were similar to our findings of cases with a combined PCIOL/PPV (62% vs 62.4% at 9 months and final follow-up, respectively) and those with vitrectomy only. 5,12 Overall, nearly 85% of the patients in our study had an improvement in BCVA at their last follow-up compared with preoperative BCVA despite ocular comorbidities. Thus, a combined approach resulted in favorable outcomes despite the longer, more complicated surgery while also increasing the chance of disease remission.…”
Section: Discussionmentioning
confidence: 72%
“…[6][7][8] In several other studies, there has been a reported reduction in the incidence of CME and disease activity in patients with intermediate uveitis who have undergone a pars plana vitrectomy (PPV) only. [9][10][11][12] A combined phacoemulsification with PPV has shown efficacy in rapid visual rehabilitation in patients with early or visually significant cataracts and concurrent vitreoretinal pathology and has shown promise in uveitic eyes, while improving visualization during retinal surgery. [13][14][15] Although unproven, it has been hypothesized that removal of proinflammatory cytokines and autologous foreign material via vitrectomy may alter the immunologic milieu within the posterior segment.…”
Section: Introductionmentioning
confidence: 99%
“…Various studies have reported to have a beneficial effect of pars plana vitrectomy on the course of uveitis and associated CME. [19] However the role of vitrectomy in the management of CME following infectious uveitis remains largely unexplored and proper studies are needed to define the role and indications of vitrectomy in these patients.…”
Section: Discussionmentioning
confidence: 99%
“…Six series emphasized vitrectomy as a specific treatment for intermediate uveitis [210][211][212][213][214][215]. For series published after 2005, the median time on medical treatment until vitrectomy was 36 months [209]. Long-term followup of a small series of pediatric patients with intermediate uveitis indicated beneficial results from pars plana vitrectomy (PPV) [216] similar to other series involving children [215,217,218].…”
Section: Vitrectomymentioning
confidence: 95%
“…Vitrectomy in the treatment of uveitis has been reviewed [208,209]. Prior to 2006, patients with intermediate uveitis accounted for half of the 1762 eyes reported in 44 interventional case series.…”
Section: Vitrectomymentioning
confidence: 99%